| Q33381492 | (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system |
| Q26746177 | A Review on Medicinal Properties of Orientin |
| Q38928804 | A functional (pro)renin receptor is expressed in human lymphocytes and monocytes. |
| Q33828844 | A local proinflammatory signalling loop facilitates adverse age-associated arterial remodeling |
| Q42991005 | A partial pathway- and network-based transformation reveals the synergistic mechanism of JA and UA against cerebral ischemia-reperfusion injury |
| Q40000765 | A role of matrix metalloproteinase-8 in atherosclerosis |
| Q47401971 | ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight |
| Q33221346 | ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression |
| Q94947170 | ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome |
| Q46978132 | Acute and 1-month effect of small-volume suction lipectomy on insulin sensitivity and cardiovascular risk |
| Q35786530 | Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure. |
| Q58775248 | Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults |
| Q42153112 | Adiponectin ameliorates angiotensin II-induced vascular endothelial damage |
| Q41867537 | Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis |
| Q35763433 | Adiponectin: an adipokine with protective features against metabolic syndrome. |
| Q34978758 | Agonistic antibody to angiotensin II type 1 receptor accelerates atherosclerosis in ApoE-/- mice |
| Q44855214 | Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study |
| Q37452257 | An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q28582091 | Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK |
| Q36377589 | Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice |
| Q36895475 | Angiotensin II induces cell growth and IL-6 mRNA expression through the JAK2-STAT3 pathway in rat cerebellar astrocytes |
| Q42495467 | Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes |
| Q30428077 | Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension |
| Q35273462 | Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways |
| Q48529784 | Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease |
| Q41825863 | Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats |
| Q38803664 | Angiotensin III increases monocyte chemoattractant protein-1 expression in cultured human proximal tubular epithelial cells |
| Q54342485 | Angiotensin III induces signal transducer and activator of transcription 3 and interleukin-6 mRNA levels in cultured rat astrocytes. |
| Q40551007 | Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke |
| Q90642845 | Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report |
| Q42100753 | Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin |
| Q47574827 | Anti-Inflammatory Subfractions Separated from Acidified Chloroform Fraction of Fenugreek Seeds (Trigonella foenum-graecum L.). |
| Q42230369 | Apolipoprotein-J prevents angiotensin II-induced apoptosis in neonatal rat ventricular cells |
| Q47706341 | Arsenite Induces Vascular Endothelial Cell Dysfunction by Activating IRE1α/XBP1s/HIF1α-Dependent ANGII Signaling |
| Q36409271 | Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene -344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation |
| Q82541446 | Association of coronary inflammation and angiotensin II with impaired microvascular reperfusion in patients with ST-segment elevation myocardial infarction |
| Q35125159 | Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study |
| Q41485144 | Association of the KLK1 rs5516 G allele and the ACE D allele with aortic aneurysm and atherosclerotic stenosis |
| Q50699659 | Associations between body mass index and the prevalence of low micronutrient levels among US adults. |
| Q37362745 | Atrial fibrillation and renin-angiotensin system |
| Q85822202 | Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension |
| Q30438756 | Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans |
| Q64951075 | Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. |
| Q39770514 | Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis |
| Q47699200 | Blood-borne Interleukin-1β Acts upon the Subfornical Organ to Upregulate the Sympathoexcitatory Milieu of the Hypothalamic Paraventricular Nucleus |
| Q28200344 | C-reactive protein (CRP)-lowering agents |
| Q80467173 | C-reactive protein and incident left ventricular hypertrophy in essential hypertension |
| Q44657547 | Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension |
| Q51800530 | Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. |
| Q34295440 | Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. |
| Q36800161 | Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. |
| Q36776710 | Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. |
| Q85179388 | Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice |
| Q40139803 | Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice. |
| Q53228386 | Clopidogrel effectively suppresses endothelial microparticle generation induced by indoxyl sulfate via inhibition of the p38 mitogen-activated protein kinase pathway. |
| Q37050156 | Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker |
| Q35236902 | Common genetic factors for depression and cardiovascular disease |
| Q90403879 | Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation |
| Q37803475 | Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system |
| Q28168105 | Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins |
| Q30488508 | Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries |
| Q36807104 | Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. |
| Q26772290 | Critical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell Function |
| Q33569541 | Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats |
| Q33758538 | Disparate Changes in the Mechanical Properties of Murine Carotid Arteries and Aorta in Response to Chronic Infusion of Angiotensin-II. |
| Q38093421 | Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart? |
| Q36752124 | Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? |
| Q45016474 | Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. |
| Q41870370 | Effect of candesartan on the expression of sclera-choroidal intercellular adhesion molecule-1 in hypercholesterolemic models. |
| Q36126089 | Effects of cold air on cardiovascular disease risk factors in rat |
| Q79335071 | Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung |
| Q33690702 | Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study |
| Q37672751 | Effects of valsartan on inflammatory and oxidative stress markers in hypertensive, hyperglycemic patients: an open-label, prospective study |
| Q38423843 | Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation |
| Q52595139 | Equisetum arvense L. Extract Induces Antibacterial Activity and Modulates Oxidative Stress, Inflammation, and Apoptosis in Endothelial Vascular Cells Exposed to Hyperosmotic Stress. |
| Q58135067 | Evaluation of Angiotensin Converting Enzyme (ACE)-Like Activity of Acellular Hemoglobin |
| Q35862479 | Expression profiles in surgically-induced carotid stenosis: a combined transcriptomic and proteomic investigation |
| Q46897927 | FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells |
| Q83190809 | Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis |
| Q35847323 | From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension |
| Q52948768 | Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion. |
| Q37109220 | Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications |
| Q37336175 | IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. |
| Q35617259 | Impact of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers on mortality of coronary artery bypass grafting. |
| Q33888662 | In vivo assessment of blood flow patterns in abdominal aorta of mice with MRI: implications for AAA localization. |
| Q45358918 | In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice |
| Q40616218 | Increased Expression of Plasminogen Activator Inhibitor-1 by Mediators of the Acute Phase Response: a Potential Progenitor of Vasculopathy in Hypertensives |
| Q48019329 | Incremental predictive value of high-sensitivity C-reactive protein for incident hypertension: the Hypertension-Diabetes Daegu Initiative study |
| Q37252413 | Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans |
| Q57021528 | Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure |
| Q44402756 | Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients |
| Q37315106 | Inflammatory cytokines in vascular dysfunction and vascular disease |
| Q53580573 | Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis. |
| Q42028373 | Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention |
| Q34785905 | Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. |
| Q35047383 | Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. |
| Q36895449 | JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation |
| Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
| Q37382499 | Lipopolysaccharide-Induced Spatial Memory and Synaptic Plasticity Impairment Is Preventable by Captopril |
| Q44967456 | Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. |
| Q37431530 | Liver stem cells and tgf-Beta in hepatic carcinogenesis. |
| Q37828412 | Local bone marrow Renin-Angiotensin system and atherosclerosis |
| Q46979873 | Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy |
| Q51679980 | Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study). |
| Q46382805 | Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study |
| Q28382772 | Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice |
| Q53934524 | Management of Diabetes with Coronary Artery Disease. |
| Q36924398 | Mast cells in vulnerable atherosclerotic plaques--a view to a kill. |
| Q34425988 | Maternal obesity induces fibrosis in fetal myocardium of sheep |
| Q38127358 | Mechanisms for cachexia in heart failure |
| Q64283956 | Mechanisms of hypertension in autoimmune rheumatic diseases |
| Q35409886 | Methylation of promoter regions of genes of the human intrauterine Renin Angiotensin system and their expression |
| Q36821166 | Molecular mechanism of vitamin D in the cardiovascular system |
| Q37638247 | Morphological and molecular changes of the myocardium after left ventricular mechanical support |
| Q44574646 | Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade |
| Q45832826 | Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells |
| Q83276631 | Myocardial migration by fibroblast progenitor cells is blood pressure dependent in a model of angII myocardial fibrosis |
| Q64099905 | NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases |
| Q93006436 | Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 Axis |
| Q51549255 | Non‐Surgical Periodontal Therapy Improves Serum Levels of C‐Reactive Protein and Edematous States in Female Patients With Idiopathic Edema |
| Q37149254 | Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells |
| Q22252221 | Obesity and Thrombosis |
| Q39108026 | Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease |
| Q86552683 | Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial |
| Q43898598 | Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice |
| Q35055601 | PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates |
| Q61187931 | Papel de la aldosterona en las alteraciones vasculares funcionales y en el proceso inflamatorio asociados a la hipertensión en ratas |
| Q44058520 | Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations |
| Q26743419 | Perirenal Edema as a potential hint towards primary hypertension-Preliminary findings in MRI breast cancer staging |
| Q36283698 | Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation |
| Q46442680 | Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway |
| Q42131539 | Pravastatin prevents aortic atherosclerosis via modulation of signal transduction and activation of transcription 3 (STAT3) to attenuate interleukin-6 (IL-6) action in ApoE knockout mice |
| Q36497297 | Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling |
| Q37427910 | Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells |
| Q44457672 | Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver |
| Q55362172 | Protective Role of Antioxidant Huskless Barley Extracts on TNF-α-Induced Endothelial Dysfunction in Human Vascular Endothelial Cells. |
| Q37725914 | Proteomics Analysis to Identify and Characterize the Biomarkers and Physical Activities of Non-Frail and Frail Older Adults |
| Q35216484 | Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension |
| Q35582289 | RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice |
| Q34583579 | Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. |
| Q35608868 | Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension |
| Q36666799 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes |
| Q44011765 | Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells. |
| Q37345864 | Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. |
| Q36610618 | Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan |
| Q50554432 | Renin‐Angiotensin System Blocker Use May Be Associated with Suppression of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation |
| Q37050143 | Risk-based classification of hypertension and the role of combination therapy |
| Q47808587 | Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts |
| Q33845139 | Role of IL-6 in angiotensin II-induced retinal vascular inflammation |
| Q51007042 | Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data. |
| Q28573076 | Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells |
| Q50986764 | Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. |
| Q36806972 | Role of inflammation in the progression of heart failure |
| Q30424339 | Role of the immune system in hypertension: modulation by dietary antioxidants |
| Q37429079 | Roles of IL-6-gp130 Signaling in Vascular Inflammation |
| Q37038026 | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species |
| Q36660171 | Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension |
| Q46898742 | Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. |
| Q31152104 | Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
| Q36526913 | Systemic inflammation in heart failure--the whys and wherefores |
| Q81668601 | Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats |
| Q45933327 | Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma. |
| Q39908598 | Telomere length and psychological well-being in patients with chronic heart failure |
| Q57643790 | The "perirenal edema sign" as a hint towards hypertension--preliminary observations on cofindings in MRI breast cancer staging |
| Q38817535 | The association between inflammation, obesity and elevated blood pressure in 16-25-year-old females |
| Q59189179 | The association of ACE I/D gene polymorphism with severe carotid atherosclerosis in patients undergoing carotid endarterectomy |
| Q34502432 | The atherogenic potential of dietary carbohydrate |
| Q33648166 | The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer |
| Q41031121 | The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells |
| Q35148421 | The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction |
| Q40309305 | The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex |
| Q27003277 | The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance |
| Q33790556 | The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q33579257 | The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6. |
| Q35087027 | The role of angiotensin II in regulating vascular structural and functional changes in hypertension |
| Q36909521 | The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus |
| Q36873154 | Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockade |
| Q36214881 | Treatment of multiple-risk patients: using combination therapy to treat beyond LDL lowering |
| Q53714172 | Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril. |
| Q88181434 | Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q40121709 | Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II. |
| Q83335866 | Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2 |
| Q39449387 | Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes |
| Q26783581 | Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide |
| Q37971254 | Vascular effects of glycoprotein130 ligands--part I: pathophysiological role |
| Q80106732 | [Inflammation in acute coronary syndromes: mechanisms and clinical implications] |